Related Experiment Video
Updated: Jun 17, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Expanded Newborn Screening in Italy: The First Report of Lombardy Region
Clarissa Berardo1,2, Alessandra Vasco2, Alessia Mauri1,2
1Pediatric Research Center "Romeo ed Enrica Invernizzi", Department of Biomedical and Clinical Sciences, University of Milan, 20157 Milan, Italy.
Insights
This study reports the incidence and distribution of inborn errors of metabolism (IEMs) identified through expanded newborn screening (NBS) in Italy's Lombardy region. The findings provide crucial data on IEM prevalence in this population.
Area of Science:
- Biochemistry
- Genetics
- Pediatrics
Background:
- Newborn screening (NBS) is vital for early detection of inborn errors of metabolism (IEMs) in asymptomatic infants.
- Early identification of IEMs reduces the risk of severe, long-term health complications.
- This study focuses on the initial years of an expanded NBS program in Lombardy, Italy.
Purpose of the Study:
- To report the incidence and distribution of IEMs in the Lombardy region.
- To evaluate the effectiveness of the expanded NBS program from 2016-2020.
- To establish baseline data for IEM prevalence in a large newborn population.
Main Methods:
- Dried blood spots collected from 343,507 newborns (48-72 hours post-birth).
- FIA-MS/MS analysis for biochemical markers.
- Genetic confirmation (Sanger or NGS) and reporting to a clinical reference center.
Main Results:
- 209 newborns diagnosed with IEMs out of 343,507 screened.
- 1208 false positive cases identified.
- Twenty-seven types of IEMs detected, including aminoacidemias, urea cycle disorders, organic acidemias, and fatty acid oxidation disorders.
Conclusions:
- This is the first report on IEM incidence and distribution in Lombardy using expanded NBS.
- The findings highlight the importance of continued NBS for early IEM diagnosis.
- Data provides a foundation for regional public health strategies concerning IEMs.
Background:
Newborn screening (NBS) is a preventive healthcare program aiming at identifying the inborn errors of metabolism (IEMs) in asymptomatic infants to reduce the risk of severe complications. The aim of this study was to report the first years (2016-2020) of the expanded NBS program in the Lombardy region, Italy.
Methods:
Dried blood spots were collected from newborns' heels at 48-72 h after birth. FIA-MS/MS was performed to evaluate specific biochemical markers. Genetic confirmation was achieved via Sanger or NGS on newborns and reported to a clinical reference center (CRC).
Results:
A total of 343,507 newborns were tested; 1414/343,507 resulted as positive to NBS and were reported to the CRC. A total of 209 newborns were diagnosed with IEMs: 206 infants received a diagnosis of IEM through NBS, confirmed by genetic analysis; three neonates were not positive to NBS but were subsequentially diagnosed with IEMs. A total of 1208/343,507 were false positive cases. Twenty-seven types of IEMs were diagnosed in 209 patients: 111 newborns were affected by aminoacidemias, 11 by urea cycle disorders, 27 by organic acidemias, 34 by fatty acid oxidation disorders, and 26 by secondary conditions.
Conclusions:
We report here for the first time the IEM incidence and distribution in the Lombardy region in the first five years of NBS.
More Related Videos
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
09:36High-Content Screening Differentiation and Maturation Analysis of Fetal and Adult Neural Stem Cell-Derived Oligodendrocyte Precursor Cell Cultures
Published on: March 10, 2021
Related Concept Videos
Introduction to Developmental Psychology
Development of Human Microbiota
Development of the Oral Microbiota